Roche, facing biosimilar threats, puts faith in new cancer and obesity drugs
Summary
On a conference call, executives claimed that a closely watched breast cancer pill and portfolio of weight loss medicines could bank more than $9 billion annual...
Description
On a conference call, executives claimed that a closely watched breast cancer pill and portfolio of weight loss medicines could bank more than $9 billion annual...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source